288 related articles for article (PubMed ID: 24319409)
1. A cholinergic hypothesis of the unconscious in affective disorders.
Vakalopoulos C
Front Neurosci; 2013; 7():220. PubMed ID: 24319409
[TBL] [Abstract][Full Text] [Related]
2. Neurocognitive deficits in major depression and a new theory of ADHD: a model of impaired antagonism of cholinergic-mediated prepotent behaviours in monoamine depleted individuals.
Vakalopoulos C
Med Hypotheses; 2007; 68(1):210-21. PubMed ID: 16997497
[TBL] [Abstract][Full Text] [Related]
3. Neuropharmacology of cognition and memory: a unifying theory of neuromodulator imbalance in psychiatry and amnesia.
Vakalopoulos C
Med Hypotheses; 2006; 66(2):394-431. PubMed ID: 16300905
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease: more than a 'cholinergic disorder' - evidence that cholinergic-monoaminergic interactions contribute to EEG slowing and dementia.
Dringenberg HC
Behav Brain Res; 2000 Nov; 115(2):235-49. PubMed ID: 11000423
[TBL] [Abstract][Full Text] [Related]
5. 192IGG-saporin-induced selective lesion of cholinergic basal forebrain system: neurochemical effects on cholinergic neurotransmission in rat cerebral cortex and hippocampus.
Rossner S; Schliebs R; Härtig W; Bigl V
Brain Res Bull; 1995; 38(4):371-81. PubMed ID: 8535860
[TBL] [Abstract][Full Text] [Related]
6. Counteractive effects of a partial (sabcomeline) and a full (RS86) muscarinic receptor agonist on deficits in radial maze performance induced by S-AMPA lesions of the basal forebrain and medial septal area.
Hodges H; Peters S; Gray JA; Hunter AJ
Behav Brain Res; 1999 Feb; 99(1):81-92. PubMed ID: 10512575
[TBL] [Abstract][Full Text] [Related]
7. Cadmium-induced cell death of basal forebrain cholinergic neurons mediated by muscarinic M1 receptor blockade, increase in GSK-3β enzyme, β-amyloid and tau protein levels.
Del Pino J; Zeballos G; Anadón MJ; Moyano P; Díaz MJ; García JM; Frejo MT
Arch Toxicol; 2016 May; 90(5):1081-92. PubMed ID: 26026611
[TBL] [Abstract][Full Text] [Related]
8. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
Šaponjić J
Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
[TBL] [Abstract][Full Text] [Related]
9. Effects of cholinergic-rich neural grafts on radial maze performance of rats after excitotoxic lesions of the forebrain cholinergic projection system--I. Amelioration of cognitive deficits by transplants into cortex and hippocampus but not into basal forebrain.
Hodges H; Allen Y; Kershaw T; Lantos PL; Gray JA; Sinden J
Neuroscience; 1991; 45(3):587-607. PubMed ID: 1775235
[TBL] [Abstract][Full Text] [Related]
10. Spatial memory deficits in aged rats: contributions of monoaminergic systems.
Luine V; Bowling D; Hearns M
Brain Res; 1990 Dec; 537(1-2):271-8. PubMed ID: 2085779
[TBL] [Abstract][Full Text] [Related]
11. M1 muscarinic agonist treatment reverses cognitive and cholinergic impairments of apolipoprotein E-deficient mice.
Fisher A; Brandeis R; Chapman S; Pittel Z; Michaelson DM
J Neurochem; 1998 May; 70(5):1991-7. PubMed ID: 9572284
[TBL] [Abstract][Full Text] [Related]
12. Agonist-induced restoration of hippocampal neurogenesis and cognitive improvement in a model of cholinergic denervation.
Van Kampen JM; Eckman CB
Neuropharmacology; 2010 May; 58(6):921-9. PubMed ID: 20026137
[TBL] [Abstract][Full Text] [Related]
13. Cholinergic system and memory in the rat: effects of chronic ethanol, embryonic basal forebrain brain transplants and excitotoxic lesions of cholinergic basal forebrain projection system.
Arendt T; Allen Y; Marchbanks RM; Schugens MM; Sinden J; Lantos PL; Gray JA
Neuroscience; 1989; 33(3):435-62. PubMed ID: 2636702
[TBL] [Abstract][Full Text] [Related]
14. M1 muscarinic receptors facilitate hippocampus-dependent cognitive flexibility via modulating GluA2 subunit of AMPA receptors.
Xiong CH; Liu MG; Zhao LX; Chen MW; Tang L; Yan YH; Chen HZ; Qiu Y
Neuropharmacology; 2019 Mar; 146():242-251. PubMed ID: 30529302
[TBL] [Abstract][Full Text] [Related]
15. The role of the central cholinergic projections in cognition: implications of the effects of scopolamine on discrimination learning by monkeys.
Harder JA; Baker HF; Ridley RM
Brain Res Bull; 1998; 45(3):319-26. PubMed ID: 9510426
[TBL] [Abstract][Full Text] [Related]
16. The potential for muscarinic receptor subtype-specific pharmacotherapy for Alzheimer's disease.
McKinney M; Coyle JT
Mayo Clin Proc; 1991 Dec; 66(12):1225-37. PubMed ID: 1749291
[TBL] [Abstract][Full Text] [Related]
17. Effects of lesion of the cholinergic basal forebrain nuclei on the activity of glutamatergic and GABAergic systems in the rat frontal cortex and hippocampus.
Reine G; Samuel D; Nieoullon A; Kerkerian-Le Goff L
J Neural Transm Gen Sect; 1992; 87(3):175-92. PubMed ID: 1581017
[TBL] [Abstract][Full Text] [Related]
18. [Neurochemical mechanisms of sleep regulation].
Glas Srp Akad Nauka Med; 2009; (50):97-109. PubMed ID: 20666118
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
